Toronto Dominion Bank
OPRX icon

Toronto Dominion Bank’s OptimizeRx OPRX Stock Holding History

Toronto Dominion Bank’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10
Closed -$100 – 1352
2024
Q2 		$100 Hold
10
– – ﹤0.01% 1354
2024
Q1 		$122 Hold
10
– – ﹤0.01% 1315
2023
Q4 		$143 Hold
10
– – ﹤0.01% 1428
2023
Q3 		$78 Hold
10
– – ﹤0.01% 1701
2023
Q2 		$0 Hold
10
– – ﹤0.01% 1709
2023
Q1 		$0 Buy
+10
New +$167 ﹤0.01% 1642

Other funds holding OPRX

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Toronto Dominion Bank's OPRX Position: Q3 2024 in Review

Toronto Dominion Bank sold out of OptimizeRx (OPRX) in Q3 2024, closing a stake of 10 shares — an estimated $100 sold.

Toronto Dominion Bank first reported a position in OPRX in Q1 2023 and held it in 6 quarters. The position peaked at $143 in Q4 2023. 85 funds tracked by Wall St. Rank hold OPRX as of Q3 2024.

  • Toronto Dominion Bank reported no remaining OptimizeRx position as of Q3 2024 after selling out during the quarter.
  • Toronto Dominion Bank sold 10 OptimizeRx shares in Q3 2024, an estimated $100.
  • Toronto Dominion Bank first reported a position in OptimizeRx in Q1 2023 and held it in 6 quarters.
  • Toronto Dominion Bank's OptimizeRx position peaked at $143 in Q4 2023.
  • 85 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2024.

Based on Toronto Dominion Bank's 13F filing for Q3 2024, filed 14 Nov 2024.